Please login to the form below

Not currently logged in
Email:
Password:

Celgene engages IBM Watson for patient safety work

Aims to improve its pharmacovigilance methods with a new cloud-based platform
Celgene

Celgene has teamed up with IBM Watson Health to improve its existing pharmacovigilance methods through the creation of a new cloud-based drug evaluation platform.

Built using the Watson Health Cloud supercomputer, the new system will collect patient data to assess, monitor and report adverse drug reactions.

IBM says the high volumes of data will be obtained from “diverse sources, including anonymised electronic medical records, medical claims databases and other healthcare information sources”.

'Watson for Patient Safety' aims to aid life sciences companies in managing and interpreting Individual Case Safety Reports (ICSRs), using its trademark cognitive computing technology to increasingly identify potential drug safety signals.

The partners hope this will reduce the time and monetary drain of failed late-stage clinical trials for drug developers through access to such comprehensive outcome- and evidence-based profiling, ultimately getting drugs to market faster.

John Freeman, Celgene's corporate vice president of global drug safety and risk management, said: “With this collaboration, we intend to create a paradigm shift in identifying patient safety data that we hope can be applied across the entire product lifecycle - from early development to approved medicines.

“The new offering we are co-developing will bring the cognitive computing power of Watson and its growing view of clinical, research and social health data to bear on this critical healthcare challenge.”

Due to be developed across several phases, the first module of 'Watson for Patient Safety' is expected to be ready within the next year.

Article by
Rebecca Clifford

3rd November 2016

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics